Provided by Tiger Trade Technology Pte. Ltd.

Global X Aging Population ETF

35.94
-0.1703-0.47%
Post-market: 35.91-0.0397-0.11%19:30 EDT
Volume:14.08K
Turnover:505.90K
Market Cap:87.35M
PE:- -
High:36.12
Open:36.12
Low:35.54
Close:36.12
52wk High:39.48
52wk Low:33.59
Shares:2.43M
Float Shares:2.43M
Volume Ratio:2.44
T/O Rate:0.58%
Dividend:0.33
Dividend Rate:0.92%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Analysts’ Top Healthcare Picks: AbbVie (ABBV), Quantum-Si (QSI)

TIPRANKS
·
Sep 29

Novo Nordisk Says Ozempic Shows Lower Risk of Cardiovascular Events Compared to Eli Lilly's Mounjaro

Reuters
·
Sep 29

Eli Lilly announces positive results from study of Foundayo 17.2 mg

TIPRANKS
·
Sep 29

Shenzhen Lifotronic Technology Secures Medical Device Registration Certificate for Photon Therapeutic Apparatus

Stock News
·
Sep 29

Rhythm Biosciences Files Updated Corporate Governance Statement With ASX

TIPRANKS
·
Sep 29

Eli Lilly's Foundayo 17.2 Mg was Associated with 1.5% Greater Weight Loss at 52 Weeks

Reuters
·
Sep 29

Lilly Says Foundayo 17.2 Mg Outperforms Oral Semaglutide 25 Mg on Weight Loss, A1C in Indirect Comparison Study

Reuters
·
Sep 29

Eli Lilly - Foundayo 17.2 Mg Shows 1.5% Greater Weight Loss and 0.3% Greater A1c Reduction at 52 Weeks

THOMSON REUTERS
·
Sep 29

Long-Term Care Insurance in Xiong'an New Area Officially Launches on October 1

Deep News
·
Sep 29

Healthpeak Properties Inc. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Sep 29

Sector Update: Healthcare

MT Newswires Live
·
Sep 29

Market Chatter: Eli Lilly CEO Plans Larger Deals to Target New Disease Areas

MT Newswires Live
·
Sep 29

Lilly CEO Eyes Bigger Deals in Hunt for Pharma's 'white Spaces' - Bloomberg News

Reuters
·
Sep 29

Eli Lilly CEO tells Bloomberg sees more deals in untapped areas

TIPRANKS
·
Sep 29

US Drugmakers Turn to China for Licensing Deals

Reuters
·
Sep 28

Taking Ozempic? a Routine Eye Exam Could Help You Understand Your Risk for Vision Loss

Dow Jones
·
Sep 28

Autagco to Close Key Pergam Assisted Living Facility After Property Sale

TIPRANKS
·
Sep 28

FDA Approves AbbVie’s JUVMO for Adults with Parkinson’s Disease

Reuters
·
Sep 28

U.S. FDA Approves Abbvie's Juvmo™ (Tavapadon) for Parkinson's Disease

THOMSON REUTERS
·
Sep 28

Abbvie - Juvmo Expected to be Available in the U.S. in October 2026

THOMSON REUTERS
·
Sep 28